PHARMACOKINETICS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
|
作者：
UEDA, T
NAKAMURA, T
ANDO, S
KAGAWA, D
SASADA, M
UCHINO, H
JOHNO, I
AKIYAMA, Y
机构：
[1] KYOTO UNIV,FAC MED,DEPT PHARM,KYOTO 606,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT PEDIAT,KYOTO 606,JAPAN
[3] FUKUI MED SCH,DEPT MED,MATSUOKA,FUKUI 91011,JAPAN
来源：
CANCER RESEARCH | 1983年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3412 / 3416
页数：5
相关论文
共 50 条
  • [31] THE SIMULTANEOUS DETERMINATION OF ARA-U AND ARA-C, URINARY METABOLITES OF N4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE BY MASS FRAGMENTOGRAPHY
    MAKINO, Y
    MATSUBARA, Y
    WATANABE, K
    HIROBE, M
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1982, 102 (01): : 49 - 55
  • [32] CELLULAR PHARMACOLOGY OF A LIPOSOMAL PREPARATION OF N-4-HEXADECYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, A LIPOPHILIC DERIVATIVE OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE
    HORBER, DH
    SCHOTT, H
    SCHWENDENER, RA
    BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 957 - 962
  • [33] INCORPORATION OF N-4-BEHENOLY-1-BETA-D-ARABINOFURANOSYLCYTOSINE (BHAC) INTO DNA AS 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C)
    HIGASHIGAWA, M
    OHKUBO, T
    KAWASAKI, H
    KAMIYA, H
    SAKURAI, M
    PEDIATRIC RESEARCH, 1988, 24 (01) : 120 - 120
  • [34] TREATMENT OF LEUKEMIA AND MYELODYSPLASTIC SYNDROMES WITH ORALLY-ADMINISTERED N-4-PALMITOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE
    OHNO, R
    HIRANO, M
    YAMAGATA, K
    OHARA, K
    SHIRAKAWA, S
    HIROTA, Y
    KOBAYASHI, M
    YOSHIKAWA, S
    MITOMO, Y
    IKEDA, Y
    MIWA, Y
    OGURI, T
    MIZUNO, H
    YAMADA, H
    YAMADA, K
    KIMURA, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (02) : 161 - 164
  • [35] COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA
    TIDEFELT, U
    SUNDMANENGBERG, B
    PAUL, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (04) : 225 - 229
  • [36] COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DAUNORUBICIN AND IDARUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA
    TIDEFELT, U
    SUNDMANENGBERG, B
    PAUL, C
    LEUKEMIA RESEARCH, 1994, 18 (04) : 293 - 297
  • [37] A PILOT-STUDY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE FOR ACUTE-LEUKEMIA AND REFRACTORY LYMPHOMA - CLINICAL-RESPONSE AND PHARMACOLOGY
    EARLY, AP
    PREISLER, HD
    SLOCUM, H
    RUSTUM, YM
    CANCER RESEARCH, 1982, 42 (04) : 1587 - 1594
  • [38] RELATIONSHIP BETWEEN INVITRO PARAMETERS OF CELLULAR 1-BETA-D-ARABINOFURANOSYLCYTOSINE TRIPHOSPHATE (ARACTP) PHARMACOKINETICS AND REMISSION DURATION OF PATIENTS (PTS) WITH ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    GRECO, WR
    AZARNIA, N
    PRIORE, RL
    PREISLER, HD
    RUSTUM, YM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 195 - 195
  • [39] ACUTE-LEUKEMIA IN PATIENTS WITH A MYELOMA - 4 CASES
    BOSSET, JF
    ROZENBAUM, A
    FLESCH, M
    LECONTEDESFLORIS, R
    LENYS, R
    NOUVELLE PRESSE MEDICALE, 1979, 8 (43): : 3562 - 3562
  • [40] CLINICAL-PHARMACOLOGY OF N-4-PALMITOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    UEDA, T
    NAKAMURA, T
    KAGAWA, D
    UCHIDA, M
    DOMAE, N
    SUGIYAMA, M
    UEDA, Y
    SASADA, M
    UCHINO, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (06) : 371 - 375
12345